Laskers Go to Immunologists, Developers of Breast Cancer Therapy
Laskers Go to Immunologists, Developers of Breast Cancer Therapy
The 2019 Lasker medical and research awards celebrate advances in scientists’ understanding of T and B cells, Herceptin antibodies for treating breast cancer, and vaccine coverage around the globe.
Laskers Go to Immunologists, Developers of Breast Cancer Therapy
Laskers Go to Immunologists, Developers of Breast Cancer Therapy

The 2019 Lasker medical and research awards celebrate advances in scientists’ understanding of T and B cells, Herceptin antibodies for treating breast cancer, and vaccine coverage around the globe.

The 2019 Lasker medical and research awards celebrate advances in scientists’ understanding of T and B cells, Herceptin antibodies for treating breast cancer, and vaccine coverage around the globe.

Herceptin
A Plea to the FDA
Cristina Luiggi | Jun 21, 2012
Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
Are Cancer Stem Cells Ready for Prime Time?
Are Cancer Stem Cells Ready for Prime Time?
Suling Liu, Hasan Korkaya, and Max S. Wicha | Apr 1, 2012
A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.